메뉴 건너뛰기




Volumn 57, Issue 5, 2006, Pages 1004-1007

Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment

Author keywords

Antigenaemia; Antiviral therapy; CMV; Cytomegalovirus

Indexed keywords

CREATININE; GANCICLOVIR;

EID: 33645829055     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl089     Document Type: Article
Times cited : (23)

References (10)
  • 1
    • 0028331004 scopus 로고
    • Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: Where do we stand?
    • Forman SJ, Zaia JA. Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: Where do we stand? Blood 1994; 83: 2392-8.
    • (1994) Blood , vol.83 , pp. 2392-2398
    • Forman, S.J.1    Zaia, J.A.2
  • 2
    • 0021934346 scopus 로고
    • Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia
    • Shepp DH, Dandliker PS, de Miranda P et al. Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia. Ann Intern Med 1985; 103: 368-73.
    • (1985) Ann Intern Med , vol.103 , pp. 368-373
    • Shepp, D.H.1    Dandliker, P.S.2    de Miranda, P.3
  • 3
    • 0022551586 scopus 로고
    • Human pharmacokinetics of the antiviral drug DHPG
    • Fletcher C, Sawchuk R, Chinnock B et al. Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther 1986; 40: 281-6.
    • (1986) Clin Pharmacol Ther , vol.40 , pp. 281-286
    • Fletcher, C.1    Sawchuk, R.2    Chinnock, B.3
  • 4
    • 0024041595 scopus 로고
    • Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function
    • Sommadossi JP, Bevan R, Ling T et al. Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function. Rev Infect Dis 1988; S507-14.
    • (1988) Rev Infect Dis
    • Sommadossi, J.P.1    Bevan, R.2    Ling, T.3
  • 5
    • 0028303991 scopus 로고
    • Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation
    • Gondo H, Minematsu T, Harada M et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol 1994; 86: 130-7.
    • (1994) Br J Haematol , vol.86 , pp. 130-137
    • Gondo, H.1    Minematsu, T.2    Harada, M.3
  • 6
    • 0037181102 scopus 로고    scopus 로고
    • Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: A prospective evaluation
    • Kanda Y, Mineishi S, Saito T et al. Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: A prospective evaluation. Transplantation 2002; 73: 568-72.
    • (2002) Transplantation , vol.73 , pp. 568-572
    • Kanda, Y.1    Mineishi, S.2    Saito, T.3
  • 7
    • 0942287029 scopus 로고    scopus 로고
    • Ganciclovir in solid organ transplant recipients: Is there a role for clinical pharmacokinetic monitoring?
    • Scott JC, Partovi N, Ensom MHH. Ganciclovir in solid organ transplant recipients: Is there a role for clinical pharmacokinetic monitoring? Ther Drug Monit 2004; 26: 68-77.
    • (2004) Ther Drug Monit , vol.26 , pp. 68-77
    • Scott, J.C.1    Partovi, N.2    Ensom, M.H.H.3
  • 8
    • 84944367245 scopus 로고
    • Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised host
    • Erice A, Jordan MC, Chace BA et al. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised host. JAMA 1987; 257: 3082-7.
    • (1987) JAMA , vol.257 , pp. 3082-3087
    • Erice, A.1    Jordan, M.C.2    Chace, B.A.3
  • 9
    • 0024040718 scopus 로고
    • Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: Experience in 314 immunocompromised patients
    • Buhles WJ, Mastre BJ, Tinker AJ et al. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: Experience in 314 immunocompromised patients. Rev Infect Dis 1988; S495-506.
    • (1988) Rev Infect Dis
    • Buhles, W.J.1    Mastre, B.J.2    Tinker, A.J.3
  • 10
    • 17744384262 scopus 로고    scopus 로고
    • Pre-emptive therapy against cytomegalovirus (CMV) diseases guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: A single-center experience in Japan
    • Kanda Y, Mineishi S, Saito T et al. Pre-emptive therapy against cytomegalovirus (CMV) diseases guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: A single-center experience in Japan. Bone Marrow Transplant 2001; 27: 437-44.
    • (2001) Bone Marrow Transplant , vol.27 , pp. 437-444
    • Kanda, Y.1    Mineishi, S.2    Saito, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.